EnginZyme Extends Series A to 11 Million to Advance Cell-Free Chemical Production Platform in Funding Round Led by Swedens Industrifonden Posted on 02/11/2021 7594

We're funded by Sofinnova Partners, Industrifonden and SEB Greentech VC, and employ some of the best researchers in their respective fields. We aim to

EnginZyme seeks to transform the $5 trillion EnginZyme, som utvecklar en teknisk plattform för hållbar produktion av kemikalier, stänger idag en förlängning av sin Serie A-finansieringsrunda, som uppgår till totalt 111 miljoner SEK. Rundan leds av Industrifonden, Sveriges största venture capitalfirma inom deep tech, och inkluderar även SEB Greentech VC samt existerande aktieägare. The extension round was led by Industrifonden followed by SEB Greentech VC and existing shareholders. “EnginZyme is demonstrating its ability to replace traditional, fossil fuel-based, energy-intensive, unsustainable chemical production with a green alternative that doesn’t compromise on efficiency,” says Patrik Sobocki, Investment Manager at Industrifonden. EnginZyme’s cell-free bio-manufacturing platform marries the efficiency of the chemical industry with the power and diversity of biology, establishing a foundation for the future chemical industry. The company is headquartered in Stockholm, Sweden. EnginZyme Extends Series A to €11 Million to Advance Cell-Free Chemical Production Platform in Funding Round Led by Sweden’s Industrifonden EnginZyme seeks to transform the $5 trillion chemical industry through the use of its enzyme-based platform, which combines the breadth and power of nature with the efficiencies of state-of-the-art chemical processing techniques EnginZyme Extends Series A to €11 Million to Advance Cell-Free Chemical Production Platform in Funding Round Led by Sweden’s Industrifonden EnginZyme, a company developing a technology platform for sustainable production of chemicals, today announced it has closed an extension to its Series A financing round, bringing the total raised to €11 million.

Se hela profilen på LinkedIn, se Patriks kontakter och hitta jobb på liknande företag. Athera (company). Athera Biotechnologies researches and develops pharmaceutical solutions for risk assessment and treatment of cardiovascular diseases. Arctic15 is the most effective matchmaking and networking event in the Nordics for startups, businesses and investors since 2011. Feb 17, 2021 The Industrifonden-led tranche has helped the Stockholm spinout lift the round to $13.3m, which will be used to conduct a proof-of-concept run. Feb 11, 2021 The extension round was driven by Industrifonden, Sweden's deep tech funding firm, followed by SEB Greentech VC and existing shareholders The extension round was driven by Industrifonden, Sweden's deep tech funding firm, followed by SEB Greentech VC and existing shareholders. “Current bio- EnginZyme is a biotechnology company that focuses on enzyme immobilization, they EnginZyme raises a $5,300,000 series A round from Industrifonden.

Feb 17, 2021 The Industrifonden-led tranche has helped the Stockholm spinout lift the round to $13.3m, which will be used to conduct a proof-of-concept run. Feb 11, 2021 The extension round was driven by Industrifonden, Sweden's deep tech funding firm, followed by SEB Greentech VC and existing shareholders The extension round was driven by Industrifonden, Sweden's deep tech funding firm, followed by SEB Greentech VC and existing shareholders. “Current bio- EnginZyme is a biotechnology company that focuses on enzyme immobilization, they EnginZyme raises a $5,300,000 series A round from Industrifonden.

February 11, 2021 01:00 AM Eastern Standard Time STOCKHOLM--(BUSINESS WIRE)--EnginZyme, a company developing a technology platform for sustainable production of chemicals, today announced it has closed an extension to its Series A financing round, bringing the total raised to €11 million.The extension round was led by Industrifonden, Sweden’s largest deep tech venture capital firm

EnginZyme Extends Series A to 11 Million to Advance Cell-Free Chemical Production Platform in Funding Round Led by Swedens Industrifonden Posted on 02/11/2021 7594 2021-02-11 EnginZyme (company). EnginZyme aims to make biocatalysis the first choice for chemical process designers worldwide. Biocatalysis offers a sustainable alternative to chemical catalysis in industry. Although the field is now half a century old, biocatalysts are not yet the default choice for chemical process designers.

EnginZyme is developing a novel technology platform to support the assembly and deployment of biological factories based on enzymes for the production of chemicals. With its biomimicking approach of production, EnginZyme achieves stellar productivity without compromising on the impact on climate or the finite resources of Earth.

Industrifonden has led a €4.6m series-A extension for Stockholm-based biotech startup EnginZyme., Early-stage, Nordics, Technology, Sweden, Sofinnova Partners, Industrifonden, Nordic venture - #private-equity #HedgeMaven EnginZyme Extends Series A to €11 Million to Advance Cell-Free Chemical Production Platform in Funding Round Led by Sweden's Industrifonden Explore EnginZyme's investment information, scientific platforms, therapeutic approaches, indications and more here! The technology developed by EnginZyme on the other hand is suitable for large-scale production and therefore has the potential to make large parts of the chemicals industry green.

EnginZyme Extends Series A to €11 Million to Advance Cell-Free Chemical Production Platform in Funding Round Led by Sweden’s Industrifonden. EnginZyme seeks to transform the $5 trillion Industrifonden has led a €4.6m series-A extension for Stockholm-based biotech startup EnginZyme., Early-stage, Nordics, Technology, Sweden, Sofinnova Partners, Industrifonden, Nordic venture The extension round was led by Industrifonden followed by SEB Greentech VC and existing shareholders.
Amnen naturvetenskapsprogrammet

Patrick Sobocki, Investment Manager. Read the company’s press release here.

EnginZyme Extends Series A to €11 Million to Advance Cell-Free Chemical Production Platform in Funding Round Led by Sweden’s Industrifonden EnginZyme seeks to transform the $5 trillion chemical industry through the use of its enzyme-based platform, which combines the breadth and power of nature with the efficiencies of state-of-the-art chemical processing techniques EnginZyme Extends Series A to €11 Million to Advance Cell-Free Chemical Production Platform in Funding Round Led by Sweden’s Industrifonden EnginZyme, a company developing a technology platform for sustainable production of chemicals, today announced it has closed an extension to its Series A financing round, bringing the total raised to €11 million. Det svenska bolaget Enginzyme vill byta ut tungmetaller i framställningen av de flesta olika produkter mot naturliga enzymer, som finns i våra celler. Bolaget får nu in Industrifonden som ny storägare.
Herr frisör stockholm

ändra firmateckning aktiebolag
tvätta fjällräven kånken
nordnet tjanstepension
ta vaccine
a1 intyg finland

The technology developed by EnginZyme on the other hand is suitable for large-scale production and therefore has the potential to make large parts of the chemicals industry green. ”By binding enzymes to a solid material, they can replace heavy metals in chemical production, and then use less energy and greatly reduce the amount of waste.

På vägen dit väntar både fabriksbygge och EnginZyme Extends Series A to €11 Million to Advance Cell-Free Chemical Production Platform in Funding Round Led by Sweden's Industrifonden Enginzyme tar in 11 miljoner euro av bland andra SEB Greentech och Industrifonden.